Protagonist Therapeutics, Inc. (PTGX)

87.50 +1.45 (+1.69%) USD  |  NASDAQ  |  Dec 22, 16:00
87.50 0.00 (0.00%) After-Hours: 16:04
More

Protagonist Therapeutics EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
MannKind Corp. Upgrade